| Italia | Turchia | Austria | |
| Tomoterapia | - | da $12,000 | da $30,000 |
| Terapia ormonale | - | da $404 | da $7,000 |
| Terapia di deprivazione androgenica | - | da $1,500 | da $4,500 |
| Terapia con protoni | - | da $70,000 | da $80,000 |
Prof. Montorsi is one of the top Italian experts in Urology and Andrology, with numerous scientific awards and 8,000+ urology/andrology surgeries. He directs the Urological Research Institute (URI) in Italy, is recognized among the most influential researchers of the past decade, and has developed his vein patching method to correct occlusive vein dysfunction. He is an Honorary Fellow of the Royal College of Surgeons of England and has written over 1,000 papers. He is a member of various medical organizations.
Professor Nadia Di Muzio is a Head of the Radiotherapy Department in the San Raffaele Research Hospital in Milan since 2008. She has a degree in general medicine and surgery and specialty in oncological radiotherapy from the University of Milan and has done an internship at the Department of Radiation Oncology in the University of Madison. Professor Di Muzio is an author of 200 studies in radiation oncology research and an advocate of high-precision hypofraction methods in the radical treatment of prostate tumors. She currently holds positions in the Italian Association of Medical Oncology, the Italian Society of Oncological Urology and the European Society for Radiotherapy and Oncology.
Dr. Alessandro Calarco is a skilled urologist with expertise in minimally invasive and endourological procedures. He performs percutaneous lithotripsy, ureterorenoscopy, tumor ablation, and advanced reconstructive surgeries. Dr. Calarco has received international recognition for his clinical work and research. He completed advanced training in Sweden and the UK.
Dr. Calarco graduated with top honors from Università Cattolica del Sacro Cuore in Rome. He completed his Urology specialization and earned a PhD in Oncological Urology at the same university. His research focuses on prostate cancer biomarkers and exosomes. He has also helped develop clinical protocols for hormone-refractory prostate cancer.
He serves as National Head of Urology for SPIGC and is a member of the European Board of Urology. Dr. Calarco holds an international patent for a device that improves percutaneous nephrolithotripsy. He has published extensively and received several awards for surgical innovation and education.
Dr. Gian Carlo Mattiucci is the Director of the Radiation Oncology Unit. He is an expert in advanced radiation therapies, such as Intensity Modulated Radiation Therapy, Stereotactic Radiation Therapy, Adaptive Radiation Therapy, and Brachytherapy. He focuses on treatment for upper gastrointestinal, prostate, and lung cancers. Dr. Mattiucci uses advanced imaging and works closely with other specialists to improve patient care.
He earned his medical degree from Università La Sapienza and completed his specialization in Radiation Oncology at Università Cattolica del Sacro Cuore in Rome. Dr. Mattiucci is an Assistant Professor at Università Cattolica. He also teaches in the ESTRO “Evidence Based Radiation Oncology” course and supports education and clinical progress in his field.